Go to ...

Boston News Globe

News Network

RSS Feed

September 21, 2017

Lexington biotech plots $86M IPO as key gene therapy trial nears


A Lexington biotech developing gene therapy treatments for rare eye diseases has announced plans to raise up to $86 million in an initial public offering.

Nightstar Therapeutics, a 23-employee company with a 3,300 square foot office in Lexington and a smaller corporate headquarters in London, said in a federal filing on Thursday that it had applied to list its shares on the Nasdaq Global Market under the ticker “NITE.”

The biotech and healthcare IPO market has picked up this year after a slow…


Source: Boston Biz

More Stories From Money